Company profile KPRX

Kiora Pharmaceuticals Inc
traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid (“cmha-s”), a modified form of the n...atural polymer hyaluronic acid (“ha”), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel (“obg”), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy (“prk”) surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone Show More
Quarter analysis & expected interestLast update: February 09 2024 02:26:44.

After 39 days of this quarter the interest is at 78.0. Based on that we can calculate that during remaining 52 days it will total up to 182.0.
Kiora Pharmaceuticals expected interest is significantly higher compared to previous quarter (+279.2%) but similar to same quarter last year.

YearQ1Q2Q3Q4
20190
88
inf% QoQ
49
-44.3% QoQ
58
18.4% QoQ
2020 100
inf% YoY 72.4% QoQ
92
4.5% YoY -8.0% QoQ
0
-100.0% YoY -100.0% QoQ
142
144.8% YoY inf% QoQ
2021 190
90.0% YoY 33.8% QoQ
275
198.9% YoY 44.7% QoQ
109
inf% YoY -60.4% QoQ
90
-36.6% YoY -17.4% QoQ
2022 67
-64.7% YoY -25.6% QoQ
21
-92.4% YoY -68.7% QoQ
240
120.2% YoY 1042.9% QoQ
203
125.6% YoY -15.4% QoQ
2023 176
162.7% YoY -13.3% QoQ
122
481.0% YoY -30.7% QoQ
295
22.9% YoY 141.8% QoQ
48
-76.4% YoY -83.7% QoQ
2024 78
-55.7% YoY 62.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Kiora Pharmaceuticals search interestLast update: February 09 2024 02:26:43.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 02:26:45.

The average 5 years interest of Kiora Pharmaceuticals was 9.36 per week.
The last year interest of Kiora Pharmaceuticals compared to the last 5 years has changed by 21.79%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 157.92%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KIO-301 clinical trial to provide analysis

Correlation between past revenue and KIO-301 clinical trial search interest

There is not enough data for KIO-301 clinical trial to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KIO-301 clinical trial to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KIO-101 eye drop to provide analysis

Correlation between past revenue and KIO-101 eye drop search interest

There is not enough data for KIO-101 eye drop to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KIO-101 eye drop to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KIO-104 posterior non-infectious uveitis to provide analysis

Correlation between past revenue and KIO-104 posterior non-infectious uveitis search interest

There is not enough data for KIO-104 posterior non-infectious uveitis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KIO-104 posterior non-infectious uveitis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for KIO-201 eye drop to provide analysis

Correlation between past revenue and KIO-201 eye drop search interest

There is not enough data for KIO-201 eye drop to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for KIO-201 eye drop to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ophthalmic diseases treatment to provide analysis

Correlation between past revenue and ophthalmic diseases treatment search interest

There is not enough data for ophthalmic diseases treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ophthalmic diseases treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for age-related degenerative retinal diseases to provide analysis

Correlation between past revenue and age-related degenerative retinal diseases search interest

There is not enough data for age-related degenerative retinal diseases to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for age-related degenerative retinal diseases to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ocular presentation of rheumatoid arthritis to provide analysis

Correlation between past revenue and ocular presentation of rheumatoid arthritis search interest

There is not enough data for ocular presentation of rheumatoid arthritis to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ocular presentation of rheumatoid arthritis to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 02:26:53.

After 39 days of this quarter the interest is at 335.0. Based on that we can calculate that during remaining 52 days it will total up to 782.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019591
813
37.6% QoQ
692
-14.9% QoQ
814
17.6% QoQ
2020 761
28.8% YoY -6.5% QoQ
591
-27.3% YoY -22.3% QoQ
880
27.2% YoY 48.9% QoQ
858
5.4% YoY -2.5% QoQ
2021 953
25.2% YoY 11.1% QoQ
969
64.0% YoY 1.7% QoQ
905
2.8% YoY -6.6% QoQ
791
-7.8% YoY -12.6% QoQ
2022 1026
7.7% YoY 29.7% QoQ
948
-2.2% YoY -7.6% QoQ
854
-5.6% YoY -9.9% QoQ
828
4.7% YoY -3.0% QoQ
2023 1023
-0.3% YoY 23.6% QoQ
929
-2.0% YoY -9.2% QoQ
840
-1.6% YoY -9.6% QoQ
794
-4.1% YoY -5.5% QoQ
2024 335
-67.3% YoY -57.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and PRK surgery search interestLast update: February 09 2024 02:26:52.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 02:26:55.

The average 5 years interest of PRK surgery was 65.88 per week.
The last year interest of PRK surgery compared to the last 5 years has changed by 1.2%.
The interest for PRK surgery is relatively stable in the last 5 years.
The last year interest is comparable to 5 years ago. It has changed only by 5.44%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for corneal wound repair to provide analysis

Correlation between past revenue and corneal wound repair search interest

There is not enough data for corneal wound repair to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for corneal wound repair to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for KPRX
Earnings date: 2024-03-21 After close
Company name: Kiora Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-30T09:00:00-04:00

PR Newswire
Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

2025-09-22T00:15:08-04:00

SEC
EFFECT Form - Notice of Effectiveness - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-09-15T16:15:51-04:00

SEC
S-3 Form - Registration statement under Securities Act of 1933 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-09-02T11:14:11Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

2025-08-08T07:14:26-04:00

SEC
8-K Form - Current report, items 2.02 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-08-08T07:01:45-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-07-31T20:30:00Z

BusinessWire
Vicarious Surgical Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer

2025-06-04T14:34:24-04:00

SEC
8-K Form - Current report, items 5.07 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-06-03T07:00:35-04:00

SEC
8-K Form - Current report, items 1.01, 7.01, and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-05-09T07:02:08-04:00

SEC
8-K Form - Current report, items 2.02 and 9.01 - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-05-09T06:59:55-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-04-30T10:00:09-04:00

SEC
DEF 14A Form - Other definitive proxy statements - KIORA PHARMACEUTICALS INC (0001372514) (Filer)

2025-04-02T20:29:26-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

2025-04-02T20:28:59-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)

2025-04-02T20:28:23-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)